Scientists Create First AI-Designed Viruses

Researchers at Stanford University used generative AI models Evo1 and Evo2 to design functional bacteriophages from scratch ^[1][3]. These synthetic viruses successfully targeted and killed antibiotic-resistant E. coli bacteria ^[1]. The study was published in the journal Science on August 6, 2026 ^[1][2].

The AI models were trained on DNA sequences to generate 16 entirely new viruses ^[2]. This breakthrough offers a potential solution for treating infections that resist traditional medicine ^[3]. However, the development raises significant biosecurity and governance concerns among the scientific community ^[1].

Experts worry about the risks of designing pathogens without strict oversight ^[1]. While these bacteriophages only target bacteria, the technology could theoretically be used for more dangerous purposes ^[1][2]. Current regulations may need updates to address these advanced biological design tools ^[1].